Huntington's Disease Treatment Market Share

Market Share of Huntington's Disease Treatment Industry

The Huntington's disease treatment market is currently fragmented with several large, small, and medium-sized players. Some of the companies currently dominating the market are Pfizer Inc., Alnylam Pharmaceuticals Inc., Ceregene Inc., Prana Biotechnology Limited, Teva Pharmaceutical Industries Ltd, Ionis Pharmaceuticals, Neurocrine Biosciences Inc., Prilenia Therapeutics, Azevan Pharmaceuticals, and Lundbeck.

Huntington's Disease Treatment Market Leaders

1. Pfizer, Inc.

2. Alnylam Pharmaceuticals Inc.

3. Teva Pharmaceutical Industries Ltd.

4. Neurocrine Biosciences, Inc.

5. Ionis Pharmaceuticals

*Disclaimer: Major Players sorted in no particular order